Table 1 Characteristics of patients
Exercise Training after AMI | Control- Patients with AMI | p | |
|---|---|---|---|
Characteristics | |||
No. of patients | 25 | 12 | n.s. |
Gender m/w | 21/4 | 7/5 | n.s. |
Age (yrs) | 60 ± 9 | 63 ± 10 | n.s. |
Body-Mass Index (kg/m2) | 27.30 ± 2.4 3 | 27.4 ± 3.94 | n.s. |
NYHA-classification | 2.64 ± 0.57 | 2.75 ± 0.62 | n.s. |
I/II/III/IV | 0/10/14/1 | 0/4/7/1 | |
BNP level, pg/ml | 121 ± 94 | 127 ± 78 | n.s. |
Coronary angiography | |||
No. of coronary vessel disease | 2.16 ± 0.83 | 2.5 ± 0.7 1 | n.s. |
1/2/3 - coronary vessel disease | 7/8/10 | 2/3/7 | |
Infarct-related coronary vessel | |||
LAD/LCX/RCA | 10/7/8 | 5/3/4 | |
No. of patients with stent, n (%) | 24 (96) | 12 (100) | |
Risk factors, n (%) | |||
Smoking | 10 (40) | 5 (42) | n.s. |
Hypercholesterolemia | 25 (100) | 12 (100) | n.s. |
Diabetes mellitus | 4 (16) | 2 (17) | n.s. |
Hypertension | 18 (72) | 9 (75) | n.s. |
Positive family History | 8 (32) | 4 (33) | n.s. |
Medication, n (%) | |||
Acetylsalicylacid | 25 (100) | 12 (100) | n.s. |
Clopidogrel | 24 (96) | 12 (100) | n.s. |
Beta-blocker | 25 (100) | 12 (100) | n.s. |
ACE-inhibitor or AT-1 antagonist | 25 (100) | 11 (90) | n.s. |
Statin | 25 (100) | 12 (100) | n.s. |
Labaratory parameters | |||
CPK [U/L] | 1196 ± 1463 | 1002 ± 1099 | n.s. |
CPK-MB (U/L) | 189 ± 259 | 136 ± 219 | n.s. |
Troponin I (ng/ml) | 21.5 ± 15.3 | 12.4 ± 9.5 | n.s. |
LDH (U/L) | 545 ± 551 | 319 ± 164 | n.s. |
CRP (mg/dl) | 5.28 ± 7.53 | 3.98 ± 5.41 | n.s. |